2m 2m 2m 2m 2m 2m 2m
INMED PHARMA (INM)
NASDAQ
$1.26-$0.04 (-2.71%)
Price as of Sep 11, 2026 6:24 PM EDT- $6.9MMarket Cap
- -39.72%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INMED PHARMA (INM)
$1.26-$0.04 (-2.71%)
INM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.29 | ||
Change | -$0.02 (-1.53%) | ||
Open | $1.33 | ||
High | $1.35 | ||
Low | $1.29 | ||
Previous Close | $1.31 | ||
Volume | 28,135 | ||
30-Day Average Volume | 72,165 | ||
1-Week Change | -6.52% | ||
1-Month Change | -11.64% | ||
1-Year Change | -39.72% | ||
3-Year Change | -93.35% | ||
5-Year Change | -99.88% | ||
Fundamentals | |||
Shares Outstanding | 5.3M | ||
Total Assets | $3.0M | ||
Market Cap | $6.9M | ||
Enterprise Value | $4.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.3M | ||
Free Cash Flow | -$3.0M | ||
EBIT | -$6.3M | ||
EBITDA | -$6.2M | ||
Net Working Capital | $721,646.00 | ||
EPS | -$1.33 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/14/2024 | ||
Earnings & Revenue